Live Breaking News & Updates on Penelope Belnap

24.04.2024 - Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates In-depth analysis of VIVIAD Phase 2b results is ongoing, including pre-specified and exploratory endpoints; findings to date . ....

Noord Holland , Morten Asser Karsdal , Frank Weber , Penelope Belnap , Kugan Sathiyanandarajah , Valeria Fisher , Ulrich Dauer , Danne Doering , Company Annual , International Accounting Standards Board , Simcere Pharmaceutical Group Ltd , Corporate Development Updates , European Union , Varoglutamstat Clinical Program , Trophic Communications , International Financial Reporting Standards , Euronext Amsterdam , Clinical Program , Cogstate Brief Battery , Amsterdam Instrumental Activities , Daily Living , Non Executive Directors , Chief Financial Officer , Investor Relations , Key Opinion Leaders , Extraordinary General Meeting ,